| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
First Department of Internal Medicine, Tottori University Faculty of Medicine (A.Y., S.T., I.H.), Yonago, Tottori 683-8504, Japan; Genome Technology Branch, National Human Genome Research Institute (I.E.R., E.D.G.), and Cell Regulation Section, Metabolic Diseases Branch, National Institute of Digestive and Diabetes and Kidney Diseases (L.D.K., K.S.), National Institutes of Health, Bethesda, Maryland 20892-8004; Ohio University School of Osteopathic Medicine and Edison Biotechnology Institute (L.D.K.), Athens, Ohio 45701-2979; and Department of Microbiology, Leprosy Research Center, National Institute of Infectious Diseases (K.S.), Tokyo 189-0002, Japan
Address all correspondence and requests for reprints to: Dr. Akio Yoshida, First Department of Internal Medicine, Tottori University Faculty of Medicine, Nishimachi 36-1, Yonago, Tottori 683-8504, Japan. E-mail: . ayoshida{at}bronze.ocn.ne.jp
Abstract
The Pendred syndrome gene encodes a 780-amino acid putative transmembrane protein (pendrin) that is expressed in the apical membrane of thyroid follicular cells. Although pendrin was shown to transport iodide and chloride using Xenopus laevis oocytes and Sf9 insect cells, there is no report using mammalian cells to study its role in thyroid function. We show here, using COS-7 cells and Chinese hamster ovary cells transfected with expression vectors encoding sodium iodide symporter or human Pendred syndrome gene cDNA and by comparison with studies using rat thyroid FRTL-5 cells, that pendrin is an iodide-specific transporter in mammalian cells and is responsible for iodide efflux in the thyroid.
This article has been cited by other articles:
![]() |
P. Wangemann, H.-M. Kim, S. Billings, K. Nakaya, X. Li, R. Singh, D. S. Sharlin, D. Forrest, D. C. Marcus, and P. Fong Developmental delays consistent with cochlear hypothyroidism contribute to failure to develop hearing in mice lacking Slc26a4/pendrin expression Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1435 - F1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dossena, S. Rodighiero, V. Vezzoli, C. Nofziger, E. Salvioni, M. Boccazzi, E. Grabmayer, G. Botta, G. Meyer, L. Fugazzola, et al. Functional characterization of wild-type and mutated pendrin (SLC26A4), the anion transporter involved in Pendred syndrome J. Mol. Endocrinol., September 1, 2009; 43(3): 93 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bizhanova and P. Kopp The Sodium-Iodide Symporter NIS and Pendrin in Iodide Homeostasis of the Thyroid Endocrinology, March 1, 2009; 150(3): 1084 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yoshida, I. Hisatome, S. Taniguchi, Y. Shirayoshi, Y. Yamamoto, J. Miake, T. Ohkura, T. Akama, O. Igawa, C. Shigemasa, et al. Pendrin Is a Novel Autoantigen Recognized by Patients with Autoimmune Thyroid Diseases J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 442 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pera, S. Dossena, S. Rodighiero, M. Gandia, G. Botta, G. Meyer, F. Moreno, C. Nofziger, C. Hernandez-Chico, and M. Paulmichl Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA PNAS, November 25, 2008; 105(47): 18608 - 18613. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nakao, S. Kanaji, S. Ohta, H. Matsushita, K. Arima, N. Yuyama, M. Yamaya, K. Nakayama, H. Kubo, M. Watanabe, et al. Identification of Pendrin as a Common Mediator for Mucus Production in Bronchial Asthma and Chronic Obstructive Pulmonary Disease J. Immunol., May 1, 2008; 180(9): 6262 - 6269. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Adler, E. Efrati, and I. Zelikovic Molecular mechanisms of epithelial cell-specific expression and regulation of the human anion exchanger (pendrin) gene Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1261 - C1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xing BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications Endocr. Rev., December 1, 2007; 28(7): 742 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Kogai, K Taki, and G A Brent Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 797 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki and L. D Kohn Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. J. Endocrinol., May 1, 2006; 189(2): 247 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-F. van den Hove, K. Croizet-Berger, F. Jouret, S. E. Guggino, W. B. Guggino, O. Devuyst, and P. J. Courtoy The Loss of the Chloride Channel, ClC-5, Delays Apical Iodide Efflux and Induces a Euthyroid Goiter in the Mouse Thyroid Gland Endocrinology, March 1, 2006; 147(3): 1287 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ma, A. Kuang, J. Xie, and T. Ma Possible Explanations for Patients with Discordant Findings of Serum Thyroglobulin and 131I Whole-Body Scanning J. Nucl. Med., September 1, 2005; 46(9): 1473 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Porra, C. Ferraro-Peyret, C. Durand, S. Selmi-Ruby, H. Giroud, N. Berger-Dutrieux, M. Decaussin, J.-L. Peix, C. Bournaud, J. Orgiazzi, et al. Silencing of the Tumor Suppressor Gene SLC5A8 Is Associated with BRAF Mutations in Classical Papillary Thyroid Carcinomas J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3028 - 3035. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Vita, L. Bauer, V. M. C. da Costa, M. De Felice, M. G. Baratta, M. De Menna, and R. Di Lauro Dose-Dependent Inhibition of Thyroid Differentiation by RAS Oncogenes Mol. Endocrinol., January 1, 2005; 19(1): 76 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Napiontek, G. Borck, W. Muller-Forell, N. Pfarr, A. Bohnert, A. Keilmann, and J. Pohlenz Intrafamilial Variability of the Deafness and Goiter Phenotype in Pendred Syndrome Caused by a T416P Mutation in the SLC26A4 Gene J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5347 - 5351. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yoshida, I. Hisatome, S. Taniguchi, N. Sasaki, Y. Yamamoto, J. Miake, H. Fukui, H. Shimizu, T. Okamura, T. Okura, et al. Mechanism of Iodide/Chloride Exchange by Pendrin Endocrinology, September 1, 2004; 145(9): 4301 - 4308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Gillam, A. R. Sidhaye, E. J. Lee, J. Rutishauser, C. W. Stephan, and P. Kopp Functional Characterization of Pendrin in a Polarized Cell System: EVIDENCE FOR PENDRIN-MEDIATED APICAL IODIDE EFFLUX J. Biol. Chem., March 26, 2004; 279(13): 13004 - 13010. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lacroix, T. Pourcher, C. Magnon, N. Bellon, M. Talbot, T. Intaraphairot, B. Caillou, M. Schlumberger, and J.-M. Bidart Expression of the Apical Iodide Transporter in Human Thyroid Tissues: A Comparison Study with Other Iodide Transporters J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1423 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kogai, Y. Kanamoto, L. H. Che, K. Taki, F. Moatamed, J. J. Schultz, and G. A. Brent Systemic Retinoic Acid Treatment Induces Sodium/Iodide Symporter Expression and Radioiodide Uptake in Mouse Breast Cancer Models Cancer Res., January 1, 2004; 64(1): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Robbins and K. S. Pentlow Coming of Age: Recombinant Human Thyroid-Stimulating Hormone as a Preparation for 131I Therapy in Thyroid Cancer J. Nucl. Med., July 1, 2003; 44(7): 1069 - 1071. [Full Text] [PDF] |
||||
![]() |
M. Xing, Y. Tokumaru, G. Wu, W. B. Westra, P. W. Ladenson, and D. Sidransky Hypermethylation of the Pendred Syndrome Gene SLC26A4 Is an Early Event in Thyroid Tumorigenesis Cancer Res., May 1, 2003; 63(9): 2312 - 2315. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |